Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO) (HB996046)

Name: Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO)
Brand: abinScience
SKU: HB996046
Price: 320 USD
Availability: InStock

Datasheet Compartir producto Copiar información

Precio(USD):

Especificación:

100ug
1mg
5mg
10mg
25mg
50mg
100mg

Número:

Contáctenos

Vista general
Imágenes
Referencias
Datasheet
SDS

Vista general

Número de catálogo	HB996046
Descripción	Blinatumomab (HB996046) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especies	Human
Aplicaciones	ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Especie huésped	Mouse
Clonalidad	Monoclonal
Isotipo	(scFv-kappa-heavy)-(scFv-heavy-kappa)
Objetivo	B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E
Nivel de endotoxinas	< 10 EU/mg
Pureza	>95% as determined by SDS-PAGE.
Purificación	Purified by Nickel column.
Número de acceso	P15391 & P07766
Forma	Liquid
Buffer de almacenamiento	30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80 Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.
Estabilidad y almacenamiento	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativos	Bispecific, CD19, AMG103, BITEMT-103, MEDI-538, MT103, bscCD19xCD3, 853426-35-4
Fondo	Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia.
Nota	For research use only. Not suitable for clinical or therapeutic use.
Isotype Control	BiTE Format Isotype Control for Bispecific Reference Antibody (HP473013)

Imágenes

SDS-PAGE

SDS-PAGE for Anti-Human CD19 & CD3 epsilon Bispecific Reference Antibody (Blinatumomab, RUO)
Bioactivity

SEC-HPLC detection for Research Grade Blinatumomab.